it-ITen-US
Healthcare is our mission
Home Therapeutic areas Respiratory
Brand name Molecule ATC Category Packaging Class
Aliflus Salmeterol + Fluticasone Propionate LABA + ICS DISKUS 50/500 mcg  A99
DISKUS 50/250 mcg A
DISKUS 50/100 mcg A
SPRAY 25/250 mcg A
SPRAY 25/125 mcg A
SPRAY 25/50 mcg A
Becotide 50 µg

Beclomethasone dipropionate

Other antiasthmatics and glucocorticoids

metered dose aerosol 10 mg A
Becotide 250 µg

Beclomethasone dipropionate

Other antiasthmatics and glucocorticoids

metered dose aerosol 50 mg A
Becotide Nasale

Beclomethasone dipropionate

Other antiasthmatics and glucocorticoids

nasal spray C
Bretaris Genuair ACLIDINIUM LABA GENUAIR 320 mcg inhaler powder Class: A Note 99
Brimica Genuair ACLIDINIUM + FORMOTEROL LABA+LAMA GENUAIR 340+12 mcg inhaler powder Class: A Note 99
Fluspiral 50
Pressurised Inhalation Suspension 		Fluticasone propionate Glucocorticoids 1 inhaler spray 50 µg (without CFC) - 120 supply A
Fluspiral 125
Pressurised Inhalation Suspension 		Fluticasone propionate Glucocorticoids 1 inhaler spray 125 µg (without CFC) - 120 supply A
Fluspiral 250
Pressurised Inhalation Suspension 		Fluticasone propionate Glucocorticoids 1 inhaler spray 250 µg (without CFC) - 120 supply A
Fluspiral Diskus 100
Inhalation Powder 		Fluticasone propionate Glucocorticoids 1 dispenser diskus 100 µg - 60 doses A
Fluspiral Diskus 250
Inhalation Powder 		Fluticasone propionate Glucocorticoids 1 dispenser diskus 250 µg - 60 doses A
Fluspiral Diskus 500
Inhalation Powder 		Fluticasone propionate Glucocorticoids 1 dispenser 500 µg - 60 doses A
Formistin Cetirizine

Systemic Antihistaminics

20 coated tablets10 mg A89
20 ml oral drops10 mg/ml A89
Salmetedur 25
Pressurised inhalation suspension

Salmeterol xinafoate

LABA 1 inhaler spray 25 µg (without CFC) - 120 supply A99
Salmetedur Diskus 50
Inhalation powder

Salmeterol xinafoate

LABA 1 dispenser diskus 50 µg - 60 doses A99

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.
Learn more +

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.
Learn more +

Pharmacovigilance

Pharmacovigilance: what does it mean to monitor drugs?
Learn more +

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2025 Istituto Lusofarmaco D'Italia S.p.A.